financetom
Business
financetom
/
Business
/
Pan American Silver Q2 revenue beats expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pan American Silver Q2 revenue beats expectations
Aug 6, 2025 2:49 PM

Overview

* Pan American Q2 revenue of $811.9 mln beats analyst expectations, per LSEG data

* Adjusted EPS of $0.43 surpasses consensus estimates, per LSEG data

* Record net earnings of $189.6 mln driven by high mine operating earnings

Outlook

* Pan American reaffirms 2025 guidance for silver production of 20-21 mln ounces

* Pan American maintains 2025 AISC guidance for silver at $16.25-$18.25/oz

* Company anticipates MAG Silver acquisition to close in H2 2025

Result Drivers

* MINE OPERATING EARNINGS - Record net earnings driven by high mine operating earnings of $273.3 mln

* JUANICIPIO ACQUISITION - Expected to increase silver production by 35% and reduce all-in sustaining costs

* DIVIDEND INCREASE - 20% increase in dividend reflects confidence in financial position

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $811.90 $700.50

Revenue mln mln (2

Analysts

)

Q2 Beat $0.43 $0.34 (5

Adjusted Analysts

EPS )

Q2 EPS $0.52

Q2 Net $189.60

Income mln

Q2 $0.1

Dividend

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the non-gold precious metals & minerals peer group is "buy"

* The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Nio Launches 1st Car Under Onvo Brand, Deliveries Set for September
Market Chatter: Nio Launches 1st Car Under Onvo Brand, Deliveries Set for September
May 15, 2024
01:52 PM EDT, 05/15/2024 (MT Newswires) -- Nio (NIO) launched L60 SUV, its first car under the new brand Onvo, with deliveries set for September, CNBC reported Wednesday. Presales for L60 SUV, which the company says will be about $4,000 cheaper than Tesla's (TSLA) comparable Model Y, started after the launch event, according to the report. Onvo will eventually start...
Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification
Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification
May 15, 2024
01:52 PM EDT, 05/15/2024 (MT Newswires) -- Takeda Pharmaceutical's ( TAK ) dengue vaccine TAK-003 received prequalification from the World Health Organization on Friday, the WHO said Wednesday. TAK-003, a vaccine containing weakened forms of four dengue virus strains, is recommended by the WHO for children aged 6 to 16 years in high-risk areas, administered in two doses with a...
Forge Resources Reports Soil Studies, Pilot Drilling at Fully-Permitted Coal Project
Forge Resources Reports Soil Studies, Pilot Drilling at Fully-Permitted Coal Project
May 15, 2024
01:50 PM EDT, 05/15/2024 (MT Newswires) -- Forge Resources ( FRGGF ) said Wednesday it initiated comprehensive soil studies and pilot drilling at La Estrella, a fully-permitted coal project in Santander, Colombia. The main objective is to characterize the area and determine the stratigraphic profile of the subsoil, the company said. Key aspects include a technical report detailing soil study...
Virpax Prices Public Offering of Shares, Warrants; Shares Tumble
Virpax Prices Public Offering of Shares, Warrants; Shares Tumble
May 15, 2024
01:55 PM EDT, 05/15/2024 (MT Newswires) -- Virpax Pharmaceuticals ( VRPX ) shares tumbled more than 65% in recent Wednesday trading after the company priced its public offering of slightly more than 1.6 million common shares and related warrants at $1.35 each for gross proceeds of nearly $2.3 million. The five-year series A-1 and 18-month series A-2 warrants to buy...
Copyright 2023-2026 - www.financetom.com All Rights Reserved